News | January 02, 2008

Abiomed Honors Tufts-New England Medical Center for Heart Recovery

January 3, 2008 – Abiomed Inc. selected Tufts-New England Medical Center (Tufts-NEMC) as a “Center of Excellence” for its cardiac program, having achieved outstanding clinical outcomes with the recovery of the native heart.

As a Center of Excellence, Tufts-NEMC will share best practices related to VAD implantation and patient care with other hospitals and medical centers. This award is granted to top institutions in the country for achieving significant clinical outcomes and their focus on recovery of the native heart. Tufts-NEMC’s outcomes are among the best in the country.

“Center of Excellence designation further exemplifies our commitment to native heart recovery and the total wellbeing of our patients,” said Afshin Ehsan, M.D., Division of Cardiothoracic Surgery at Tufts-NEMC. “Tufts-New England Medical Center’s continued success in recovering patients’ hearts, evidenced by the recovered patients able to join us today, is due to the clinical excellence and dedication of our entire cardiac team.”

Tufts-NEMC has supported more than 20 patients with Abiomed technologies. In addition, as the only Abiomed training center in New England, Tufts-NEMC conducts ongoing certification training for other hospitals.

Abiomed is a provider of medical technologies that provide circulatory support to acute heart failure patients across the continuum of care in heart recovery, enabling the heart to rest, heal and recover by improving blood flow and/or performing the pumping of the heart.

For more information: www.tufts-nemc.org and www.abiomed.com


Related Content

News | Ventricular Assist Devices (VAD)

October 31, 2023 — Tenaya Therapeutics, Inc., a clinical-stage biotechnology company with a mission to discover, develop ...

Home October 31, 2023
Home
News | Ventricular Assist Devices (VAD)

June 7, 2023 — Magenta Medical Ltd. has announced the initiation of its FDA-approved Early Feasibility Study with the ...

Home June 07, 2023
Home
News | Ventricular Assist Devices (VAD)

March 1, 2023 — Mesoblast Limited, global leader in allogeneic cellular medicines for inflammatory diseases, today ...

Home March 01, 2023
Home
News | Ventricular Assist Devices (VAD)

November 2, 2022 — For decades, left ventricular-assist devices (LVADs) have extended the lives of people whose hearts ...

Home November 02, 2022
Home
News | Ventricular Assist Devices (VAD)

October 18, 2022 — The U.S. Food and Drug Administration (FDA) is providing updates to the FDA website to include ...

Home October 18, 2022
Home
News | Ventricular Assist Devices (VAD)

August 25, 2022 — The U.S. Food and Drug Administration (FDA) issued a statement that Medtronic, Inc. is recalling ...

Home August 25, 2022
Home
News | Ventricular Assist Devices (VAD)

August 5, 2022 — Black people and women with severe heart failure who might be good candidates for surgery to implant a ...

Home August 05, 2022
Home
News | Ventricular Assist Devices (VAD)

June 23, 2022 — Medtronic, Inc. is recalling a single lot of HeartWare HVAD System batteries due to welding defects that ...

Home June 23, 2022
Home
News | Ventricular Assist Devices (VAD)

June 8, 2022 — The U.S. Food and Drug Administration (FDA) has issued a release stating that Medtronic is recalling the ...

Home June 08, 2022
Home
News | Ventricular Assist Devices (VAD)

April 28, 2022 — The U.S. Food and Drug Administration (FDA) is alerting healthcare providers to the possibility that ...

Home April 28, 2022
Home
Subscribe Now